PDGFRA and gastrointestinal stromal tumor: The majority were known to harbor KIT mutations (n = 41, 89.1%), while 3 patients (NCCS-GIST-06, NCCS-GIST-43, and NCCS-GIST-44) were PDGFRA exon 18 D842V mutants and KIT wild type.